Source: ClinicaSpace

Alcyone Life Sciences: Alcyone Lifesciences Announces Research Collaboration With a Leading Biopharmaceutical Company to Improve Intrathecal Delivery of Therapies for Rare and Orphan Neurological Conditions

Alcyone's proprietary Pulsar advanced precision CNS delivery platform utilizes the cerebrospinal fluid dynamics to precision deliver and optimally biodistribute therapeutics to targets of interest in the CNS.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
PJ Anand's photo - President & CEO of Alcyone Lifesciences, Inc.

President & CEO

PJ Anand

CEO Approval Rating

83/100

Read more